IMF Chairman Dr. Brian G.M. Durie weighed in on the high cost of cancer drugs after the recent article in Mayo Clinic Proceedings. He discusses what needs to be done within the healthcare system to better serve the patients.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.